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Effect of Obesity and Overweight
on Left Ventricular Diastolic Function
A Community-Based Study in an Elderly Cohort
Cesare Russo, MD,* Zhezhen Jin, PHD,† Shunichi Homma, MD,* Tatjana Rundek, MD,‡
Mitchell S. V. Elkind, MD,§ Ralph L. Sacco, MD,‡ Marco R. Di Tullio, MD*
New York, New York; and Miami, Florida
Objectives The purpose of this study was to assess the independent effect of increased body size on left ventricular (LV)
diastolic function.
Background Obese and overweight persons are at increased risk of heart failure. Left ventricular diastolic dysfunction is an
asymptomatic condition associated with future heart failure. It is unclear whether obesity and overweight are
independently associated with LV diastolic dysfunction.
Methods The LV diastolic function was evaluated in 950 participants from the CABL (Cardiovascular Abnormalities and
Brain Lesions) study by traditional and tissue Doppler imaging. Peak early transmitral diastolic flow velocity (E),
late transmitral diastolic flow velocity (A), and early diastolic mitral annulus velocity (E=) were measured, and
E/A and E/E= were calculated. The study sample was divided into 3 groups: normal weight (body mass index
[BMI] 25.0 kg/m2), overweight (BMI 25.0 to 29.9 kg/m2), and obese (BMI 30 kg/m2).
Results In multivariate analyses, BMI was independently associated with higher E, A, and E/E=, an indicator of LV filling
pressure (all p  0.01). Overweight and obese had lower E= (both p  0.01) and higher E/E= (both p  0.01)
than normal weight participants. The E/A was lower in obese subjects than in normal weight subjects (p 
0.01). The risk of diastolic dysfunction was significantly higher in overweight subjects (adjusted odds ratio: 1.52,
95% confidence interval: 1.04 to 2.22) and obese subjects (adjusted odds ratio: 1.60, 95% confidence interval:
1.06 to 2.41) compared to normal weight subjects.
Conclusions Increased BMI was associated with worse LV diastolic function independent of LV mass and associated risk fac-
tors. The increased risk of LV diastolic dysfunction in both overweight and obese persons may partially account
for the increased risk of heart failure associated with both conditions. (J Am Coll Cardiol 2011;57:1368–74)
© 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.10.042The prevalence of obesity is steadily increasing worldwide,
and constitutes a major health issue because of its associa-
tion with morbidity, mortality, and cardiovascular diseases
(1–3). Obesity is an independent predictor of incident heart
failure in the general population, and evidence exists that
overweight also carries an increased risk of heart failure,
which is intermediate between that of obese and lean
persons (4,5). An increase in body size, besides being
From the *Department of Medicine, Columbia University, New York, New York;
†Department of Biostatistics, Columbia University, New York, New York; ‡Depart-
ment of Neurology, Miller School of Medicine, University of Miami, Miami, Florida;
§Department of Neurology, Columbia University, New York, New York; and the
Department of Epidemiology and Human Genetics, Miller School of Medicine,
University of Miami, Miami, Florida. This work was supported by the National
Institute of Neurological Disorders and Stroke (grant number R01 NS36286 to Dr.
Di Tullio, and grant number R37 NS29993 to Drs. Sacco and Elkind). The authors
have reported that they have no relationships to disclose.Manuscript received August 23, 2010; revised manuscript received October 26,
2010, accepted October 28, 2010.associated with cardiovascular risk factors such as hyperten-
sion, diabetes mellitus, and hyperlipidemia, directly affects
cardiac structure and function. The excess in body fat
determines an increase in both pre-load and afterload due to
a hyperdynamic circulation, chronic volume overload, and
increase in peripheral resistance (6,7). In addition, it has
been demonstrated that increased adiposity enhances the
effect of blood pressure on left ventricular (LV) mass growth
(8). As a result, LV dilation and increased LV mass are
frequent findings in persons with increased body weight,
with both eccentric and concentric LV geometric patterns
described in these conditions (9–11).
Left ventricular diastolic dysfunction is a condition that
reflects an impairment of the filling properties of the left
ventricle that has been demonstrated to be a predictor of
future development of heart failure in population settings
(12–15). Left ventricular diastolic dysfunction might, there-
fore, represent one of the pathophysiological links between
r
t
m
a
1369JACC Vol. 57, No. 12, 2011 Russo et al.
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failure. Cardiovascular risk factors and cardiac structural
changes associated with obesity/overweight are also major
determinants of LV diastolic function (16,17). Whether an
increased body weight is associated with an impairment of LV
diastolic mechanics, independent of associated risk factors, has
not been fully established. Accordingly, the aims of our study
were: 1) to analyze the association between body size and LV
diastolic function, assessed by transthoracic echocardiography,
in a community-based cohort of subjects over age 50 years;
2) to evaluate the impact of associated risk factors on this
relationship; and 3) to investigate the effect of different
degrees of increased body size on the risk of LV diastolic
dysfunction.
Methods
Study population. The study cohort was derived from the
NOMAS (Northern Manhattan Study), a population-based
prospective study evaluating the incidence, risk factors, and
clinical outcome of stroke in the population of northern
Manhattan. Study design and methodological details have
been described previously (18). From September 2005, the
NOMAS subjects 50 years of age who voluntarily agreed
to undergo a brain magnetic resonance imaging study and a
more extensive echocardiographic evaluation including dia-
stolic function assessment were included in the CABL
(Cardiac Abnormalities and Brain Lesion) study. This
subset of subjects constitutes the study population of the
present report. Informed consent was obtained from all
study participants. The study was approved by the institu-
tional review board of Columbia University Medical Center.
Risk factors assessment. Hypertension was defined as
systolic blood pressure 140 mm Hg or diastolic blood
pressure 90 mm Hg at the time of the visit (mean of 2
eadings), or the patient’s self-reported history of hyper-
ension or use of antihypertensive medications. Diabetes
ellitus was defined as fasting blood glucose 126 mg/dl
or the patient’s self-reported history of diabetes or use of
diabetes medications. Hypercholesterolemia was defined
as total serum cholesterol 240 mg/dl, and the patient’s
self-report of hypercholesterolemia or use of lipid-
lowering treatment. Body mass index (BMI) was calcu-
lated as weight (kg) divided by height-squared (m2).
According to a standard definition, overweight was de-
fined as BMI between 25.0 and 29.9 kg/m2, and obesity
s BMI 30 kg/m2 (19).
Echocardiographic assessment. Transthoracic echocardi-
ography was performed using a commercially available system
(iE 33, Philips, Andover, Massachusetts) by a trained regis-
tered sonographer following a standardized protocol. The
LV linear dimensions were measured from a parasternal
long-axis view according to the recommendations of the
American Society of Echocardiography (20). The LV masswas calculated with a validated
formula (21) and indexed both
for body surface area (BSA) and
height2.7 (22). The LV relative
wall thickness was calculated as
follows: (2  posterior wall thick-
ness) divided by end-diastolic di-
ameter (23). The LV ejection frac-
tion was calculated by biplane
modified Simpson’s rule.
Left ventricular diastolic func-
tion assessment has been de-
scribed previously in detail (17). Briefly, from an apical
4-chamber view, transmitral flow was sampled by pulsed-
wave Doppler at the level of mitral valve leaflet tips. Peak
velocities of the early phase (E) and late phase (A) of the
mitral inflow were measured, and their ratio (E/A) was
calculated. Left ventricular myocardial velocities were eval-
uated by tissue Doppler imaging (TDI). Pulsed TDI sample
volume was placed at the level of the lateral and septal mitral
valve annulus, and the peak early diastolic velocities (E=)
were measured and then averaged (24). The ratio between E
and E= (E/E=) was calculated as an index of LV filling
pressures (25). Diastolic dysfunction was defined as 1) E/A
0.7 (impaired relaxation, grade I); or 2) E/A 0.7 and
1.5 and E=7 cm/s (pseudonormalized pattern, grade II);
or 3) E/A 1.5 and E= 7 cm/s (restrictive pattern, grade
III) (17,24).
Statistical analysis. Data are presented as mean  SD for
continuous variables and as proportions for categorical
variables. Differences between groups were assessed by
1-way analysis of variance and post-hoc multiple compari-
sons were performed using the Bonferroni correction. The
Fisher’s exact test was used to test differences between
proportions. Multiple linear regressions were used to assess
the independent association of BMI with diastolic function
parameters. The predictors and the outcome variables were
standardized with corresponding standard deviations and
both nonstandardized (B) and standardized () coefficient
estimates and relative standard errors were reported. Cova-
riates (age, sex, LV mass/height2.7, heart rate, hypertension,
and diabetes) were entered in the models in a stepwise
fashion, with entry and removal criteria set at a p  0.1.
Analysis of covariance was conducted to assess differences
in diastolic function parameters between groups after
adjusting for covariates. Estimated marginal means ad-
justed for covariates and 95% confidence intervals (CIs)
were derived. Multivariate logistic models were used to
assess the risk of diastolic dysfunction associated with
body size measures, and odds ratios (ORs) and relative
95% CI were derived.
For all statistical analyses, a 2-tailed p  0.05 was
considered significant. Statistical analyses were performed
using SPSS software version 17.0 (SPSS, Inc., Chicago,
Abbreviations
and Acronyms
BMI  body mass index
BSA  body surface area
CI  confidence interval
LV  left ventricular
OR  odds ratio
TDI  tissue Doppler
imagingIllinois).
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Study population. The study population consisted of 950
participants. The study sample was divided into 3 groups:
subjects with a BMI 25.0 kg/m2 (normal weight group,
 242), subjects with a BMI between 25.0 and 29.9
g/m2 (overweight group, n  403), and subjects with a
BMI 30 kg/m2 (obese group, n  305). Demographic,
clinical, and echocardiographic characteristics of the 3
groups are shown in Table 1.
BMI, LV mass, and cardiovascular risk factors. Since
obese and overweight participants showed higher LV mass
when indexed by height2.7, but also greater prevalence of
cardiovascular risk factors, which may in turn be responsible
for an increased LV mass and worse diastolic function, we
explored the independent association of BMI and cardio-
vascular risk factors with LV mass. A higher BMI was the
strongest independent predictor of increased LV mass/
height2.7 (  0.28, p  0.001). Other independent
redictors in the model were age (  0.15, p  0.001),
ypertension (  0.17, p  0.001), and diabetes ( 
.07, p  0.02). Sex was not associated with LV mass index
fter adjustment for BMI (  0.03, p  0.23). When
LV mass was indexed by BSA instead of height2.7, no
significant residual association was found between BMI and
LV mass (  0.008, p  0.81).
MI and diastolic function parameters. The correlation
etween BMI and echocardiographic diastolic function
arameters was tested in stepwise multivariate linear regres-
ion models (Table 2). Higher BMI was associated with
igher peak E-wave (R2  0.05; p  0.006), higher peak
A-wave (R2  0.22; p  0.001), lower E/A (R2  0.08;
Characteristics of the Study Population by BMITable 1 Characteristics of the Study Popula
Characteristics
(n  950)
Normal Weight
(BMI <25.0 kg/m
(n  242)
Clinical/demographic data
Age, yrs 73.9 10.3
Women 135 (55.8)
BMI, kg/m2 22.6 1.9
Waist circumference, cm 85.4 8.7
Systolic BP, mm Hg 132.4 18.3
Diastolic BP, mm Hg 75.2 9.8
Hypertension 149 (61.6)
Diabetes mellitus 47 (19.4)
Hypercholesterolemia 142 (58.7)
Echocardiographic data
End-diastolic diameter, cm/m 2.71 0.28
LV mass, g 172.4 52.5
LV mass/height2.7, g/m2.7 46.1 14.2
LV mass/BSA, g/m2 104.5 30.4
Relative wall thickness 0.49 0.09
LV ejection fraction, % 62.2 8.2
Heart rate, beats/min 68.4 10.7
Values are mean  SD or n (%). Multiple comparisons were carried o
normal weight. ‡p  0.01 versus overweight.
BMI  body mass index; BP  blood pressure; BSA  body surface area; Lp  0.01), and higher E/E= ratio (R2  0.20; p  0.001),
independent of factors influencing LV diastolic function
including age, sex, LV mass, hypertension, diabetes, and
heart rate.
In separate subanalyses by sex adjusted for age and LV
mass index, we found that among men, BMI was signifi-
cantly correlated with higher A (  0.14, p  0.01), lower
/A (  0.12, p  0.03), and lower E= (  0.12, p 
.02). Among women, BMI was significantly correlated with
igher E (  0.15, p  0.001), higher A (  0.17, p 
.001), and higher E/E= (  0.12, p  0.003).
In a subanalysis of subjects without hypertension and
diabetes (n  223), the relation between BMI and E/E=
atio was still significant (  0.13, p  0.04) independent
of age, LV mass index, and heart rate (variables that were
selected in the stepwise model; data not shown).
LV diastolic function in overweight and obesity. In
multivariate comparisons (Table 3), peak E was significantly
higher in obese subjects than in normal weight subjects (p
0.01). Peak A was significantly higher in the overweight
group and the obese group (both p  0.01) compared with
the normal weight group. The E/A ratio was significantly
lower in obese patients compared with normal weight
subjects (p  0.01). Peak E= was significantly lower in
overweight subjects and obese subjects compared with
normal weight persons (both p  0.01). The E/E= ratio was
significantly higher in overweight subjects and obese sub-
jects compared with normal weight persons (both p 0.01).
Prevalence of LV diastolic dysfunction in the overall
sample was 53.5% (n  508). Diastolic dysfunction was
present in 50.8% of the normal weight group, in 54.2% of
goriesby BMI Categories
Overweight
(BMI 25.0–29.9 kg/m2)
(n  403)
Obese
(BMI >30.0 kg/m2)
(n  305)
70.9 8.9* 70.7 8.8*
233 (57.8) 216 (70.8)*‡
27.4 1.5* 33.8 3.4*‡
95.0 8.3* 106.4 10.7*‡
135.9 16.1† 138.5 18.2*
78.6 9.4* 79.8 9.3*
284 (70.5)† 251 (82.3)*‡
112 (27.8)† 116 (38.0)*‡
254 (63.0) 197 (64.8)
2.77 0.28† 2.86 0.29*‡
179.2 47.5 196.2 47.8*‡
49.3 13.1* 56.0 14.0*‡
101.7 24.8 104.3 24.4
0.49 0.09 0.51 0.09
63.2 7.4 64.5 6.7*
70.7 11.4† 70.1 11.6
the Bonferroni correction method. *p  0.01 and †p  0.05 versusCatetion
2)
ut withV  left ventricle.
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March 22, 2011:1368–74 Obesity, Overweight, and LV Diastolic Functionthe overweight group, and in 57.1% of the obese group (p
.34). A pseudonormalized diastolic pattern was present in
6.7% of the normal weight group, 17.7% of the overweight
roup, and 24.3% of the obese group (p  0.04). A
multivariate logistic model was used to assess the risk of LV
diastolic dysfunction associated with the presence of over-
weight and obesity (Table 4). After adjusting for covariates,
both the overweight group (OR: 1.52, 95% CI: 1.04 to 2.22,
p  0.03) and the obese group (OR: 1.60, 95% CI: 1.06 to
.41, p  0.02) had a significantly higher risk of diastolic
dysfunction compared with the normal weight group. Body
mass index as a continuous variable was also significantly
associated with increased risk of diastolic dysfunction (ad-
justed OR for each BMI unit increase: 1.04, 95% CI: 1.01
to 1.07, p  0.04) and of pseudonormalized diastolic
pattern (adjusted OR for each BMI unit increase: 1.05, 95%
CI: 1.01 to 1.08, p  0.02). No significant interaction was
found between sex and BMI on LV diastolic dysfunction
(p value for the interaction  0.61).
Waist circumference and LV diastolic function. All the
previous analyses were also performed using the waist
circumference as a measure of abdominal adiposity, in lieu
of the BMI. In the multivariate linear regression analysis,
waist circumference was significantly associated with peak A
(  0.11, p  0.001) and with E/A (  0.06, p 
0.05). In the multivariate logistic model, an increased waist
circumference (defined as 88 cm in women and 102 cm
in men) was associated with a significant increase in risk of
diastolic dysfunction (adjusted OR: 1.69, 95% CI: 1.22 to
2.35, p  0.002). Waist circumference as a continuous
variable was also significantly associated with an increased
risk of diastolic dysfunction (adjusted OR for each unit
increase: 1.03, 95% CI: 1.01 to 1.04, p  0.01). No
significant interaction was found between sex and waist
circumference on LV diastolic dysfunction (p value for the
interaction  0.88).
Discussion
We analyzed the association between measures of body size
and LV diastolic function, measured by traditional Doppler
analysis of mitral inflow and TDI-derived parameters, in an
elderly, randomly derived community cohort. Our findings
indicate that: 1) the relationship between BMI and diastolic
function parameters is continuous and independent of
cardiovascular risk factors that cluster with obesity, such as
hypertension, diabetes, and LV hypertrophy; and 2) the
overweight status is already associated with an impairment
of LV diastolic function, close to that observed in obese
persons. In fact, no significant differences were found in
most parameters of diastolic function between obese and
overweight subjects.
This observation was also confirmed by the similar OR
for diastolic dysfunction associated with both conditions.
Overweight and obese subjects had also higher risk of a
pseudonormalized diastolic pattern. The use of TDI param-Re T Val
u
pe
ak A
ight. †p
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allowed us to detect diastolic abnormalities in 183 subjects
(19.6% of the study sample) who would otherwise have been
classified as normal by Doppler flow analysis alone. Further-
more, the use of E/E= ratio, a widely used indicator of LV
filling pressure (25) and an independent predictor of cardiac
events including heart failure and myocardial infarction (27),
revealed higher LV filling pressures in obese and overweight
patients than in normal weight subjects. Cardiovascular risk
factors were significantly more prevalent among overweight
and obese persons than among normal weight persons. It is
established that hypertension, diabetes, and increased LV mass
negatively affect LV diastolic function (16,17). However, BMI
was still associated with LV diastolic function parameters after
controlling for hypertension and diabetes. A subanalysis per-
formed on subjects without hypertension and diabetes further
confirmed these findings. Moreover, the increased LV mass that
we observed in overweight/obese patients was not just the result of
the greater prevalence of cardiovascular risk factors in these
subgroups. In fact, BMI was the main predictor of LV mass,
independent of the presence of hypertension and diabetes.
Although the increased LV mass might be a contributor
to the impairment of diastolic function observed in the
overweight and obese groups, the relationship between BMI
and diastolic function parameters was only slightly weak-
ened by the adjustment for LV mass and other covariates,
suggesting that different mechanisms may link the increase
in BMI with the impairment in LV diastolic properties. In
fact, there is ample evidence that the accumulation of
adipose tissue may determine cardiovascular alterations in
several metabolic and neurohormonal pathways, causing
abnormalities in sodium handling, neuroendocrine activa-
tion, the renin-angiotensin-aldosterone system, and increas-
ing myocardial oxidative stress (28,29). Changes in myocar-
dial metabolism have been demonstrated in obese patients,
Diastolic Function Parameters by BMI CategorieTable 3 Diastolic Function Parameters by B
Normal Weight
(BMI <25.0 kg/m2)
(n  242)
Peak E, cm/s 69.1 (1.2)
Peak A, cm/s 84.2 (1.2)
E/A ratio 0.87 (0.02)
Peak E=, cm/s 7.5 (0.1)
E/E= ratio 9.9 (0.2)
Values in the table are means adjusted for covariates. Covariates: a
mellitus (standard error in parentheses). *p  0.01 versus normal we
Abbreviations as in Tables 1 and 2.
Risk of Diastolic Dysfunction Associated With OTable 4 Risk of Diastolic Dysfunction Assoc
Odds Ratio* 95% CI
Normal weight Reference —
Overweight 1.66 1.15–2.40
Obese 1.92 1.30–2.83*Adjusted for age and sex. †Adjusted for age, sex, left ventricular mass inde
CI  confidence interval.with a shift toward free fatty acid utilization and subsequent
cardiac lipotoxicity, resulting in cardiomyocyte apoptosis
and reduced cardiac efficiency (30,31). In particular, myo-
cardial fatty infiltration in obese patients may affect the
cardiac structure and function, leading to the development
of severe diastolic dysfunction (32,33).
This is the first large-scale study to evaluate the relation
between increased body weight and LV diastolic function,
in a randomly selected, elderly cohort, and to account for
many factors that would have potentially affected diastolic
function. In particular, we are the first to demonstrate that
an impairment of diastolic function may already be present
in overweight persons. Previous reports had shown a rela-
tionship between obesity and diastolic function in extremely
selected samples of young women (34–36), in subjects
without cardiovascular risk factors (37), or in extremely
obese subjects (38,39). In a large study involving patients
who underwent diagnostic coronary angiography, LV end-
diastolic pressure was significantly higher in obese patients
than in patients with a BMI 25 kg/m2 (40). Surprisingly,
in that study, no adjustment was performed for associated
risk factors and comorbidities affecting diastolic function.
Another study reported that waist circumference, but not
BMI, was correlated to lower ventricular filling (41), which
is in agreement with our findings. That study, however, did
not perform TDI evaluation, which in our study allowed us
to reveal a correlation between BMI and LV filling pressure.
Study limitations. Our evaluation of LV diastolic function
by Doppler flow analysis did not include parameters such as
isovolumic relaxation time, mitral valve deceleration time, or
pulmonary venous flow. However, those parameters suffer
from high load dependence, and the use of tissue Doppler
parameters allowed us to detect diastolic abnormalities even
when a pseudonormalized flow pattern was present. The mean
age of the study cohort was high, and so was the prevalence of
ategories
Overweight
MI 25.0–29.9 kg/m2)
(n  403)
Obese
(BMI >30.0 kg/m2)
(n  305)
70.9 (0.9) 73.0 (1.0)*
89.1 (1.0)* 92.7 (1.1)*†
0.84 (0.02) 0.81 (0.02)*
7.2 (0.08)* 7.0 (0.09)*
10.7 (0.2)* 11.1 (0.2)*
, left ventricular mass index, heart rate, hypertension, and diabetes
 0.05 versus overweight.
eight and ObesityWith Overweight and Obesity
lue Odds Ratio† 95% CI p Value
Reference — —
06 1.52 1.04–2.22 0.03
01 1.60 1.06–2.41 0.02sMI C
(B
ge, sexverwiated
p Va
—
0.0
0.0x, heart rate, hypertension, and diabetes mellitus.
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extrapolated to younger populations with lower cardiovascular
risk profiles.
Conclusions
LV diastolic dysfunction may be one of the pathophysio-
logical links between overweight/obesity and the associated
risk of having heart failure (4). Whereas in the past
attention was paid essentially to obesity, our study demon-
strates that subclinical signs of LV diastolic function im-
pairment are present in overweight subjects too, and that
these abnormalities are independent of associated risk fac-
tors. Therapeutic strategies aimed at promoting optimal
body weight resulted in improvements in LV systolic and
diastolic function (42,43), and might have a beneficial effect
in preventing or delaying the future development of heart
failure, a hypothesis that deserves further investigation.
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